Biotech RadarJobs updated

COMPANY

CloudCath

HQ: San Francisco, CA source · cloudcath.com ↗

FDA-cleared device company

Location: San Francisco, CA · source · Oct 13, 2026

Profile checked Oct 10, 2026

Keywords: Peritoneal Dialysis-associated Peritonitis End Stage Renal Disease Urinary Tract Infections Peritonitis CloudCath System CloudCath Monitoring System

4Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis source ↗
  2. Trial start —: In Vitro Analysis of Human Urine With the CloudCath Device source ↗
  3. Trial start —: A Prospective Clinical Study of the CloudCath System During In-home Peritoneal Dialysis source ↗
  4. Trial start —: In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath Device source ↗

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT04950582In Vitro Analysis of Human Urine With the CloudCath DeviceNot listedSuspendedJun 4, 2021Jun 15, 2024 (estimated)
NCT05300191In Vitro Analysis of Effluent Dialysate Solution From Patients on Peritoneal Dialysis, With the CloudCath DeviceNot listedSuspendedSep 15, 2018Dec 31, 2024 (estimated)
NCT05285436A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal DialysisNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Mar 16, 20222024-12 (estimated)
NCT04515498A Prospective Clinical Study of the CloudCath System During In-home Peritoneal DialysisNot listedCompletedAug 19, 2020Mar 31, 2023 (actual)
Feedback